Global Amblyopia Market Size, Share, and COVID-19 Impact Analysis, Global Amblyopia Market, By Type (Strabismic Amblyopia, Refractive Amblyopia, Deprivation Amblyopia, & Others), By Diagnosis (Visual Acuity Test and Photo Screening), By Treatment (Glasses, Eye Patches, Atropine Drops, & Surgery), By End Users (Hospitals & Pharmacies, and Ophthalmic Clinics), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032Industry: Healthcare
Global Amblyopia Market Insights Forecasts to 2032
- The Global Amblyopia Market Size was valued at USD 4.6 Billion in 2022.
- The Market is growing at a CAGR of 5.5% from 2022 to 2032.
- The Worldwide Amblyopia Market size is expected to reach USD 7.9 Billion by 2032.
- North America is expected to grow the fastest during the forecast period.
Get more details on this report -
The Global Amblyopia Market Size is expected to reach USD 16.3 Billion by 2032, at a CAGR of 5.5% during the forecast period 2022 to 2032.
Amblyopia, often known as lazy eye syndrome, is a condition wherein faulty visual development very early in childhood results in impaired vision in one eye. The illness often starts to manifest at birth and lasts for up to 7 years. It is the main reason why children's vision is diminished. The eye with worse vision may often be corrected using glasses or contact lenses, or occasionally with patching therapy. When there is a significant disparity in the two eyes' capacity to concentrate, amblyopia results. Other visual issues are the most frequent cause of amblyopia. Treatment of these additional disorders is crucial to prevent amblyopia, which develops when the brain learns to rely more heavily on the eye for improved vision. Due to the increasing prevalence of myopia and hypermetropia throughout the world, major participants in the market for amblyopia treatments are expanding their manufacturing capacities. certain initiatives are helping businesses meet the general demand for prescription glasses required for certain eye conditions.
This research report categorizes the global amblyopia market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global amblyopia market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global amblyopia market. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market.
Global Amblyopia Market Report Coverage
|Market Size in 2022:||USD 4.6 Billion|
|Forecast Period 2022-2032 CAGR:||5.5%|
|2032 Value Projection:||USD 7.9 Billion|
|Historical Data for:||2018-2021|
|No. of Pages:||200|
|Tables, Charts & Figures:||100|
|Segments covered:||By Type, By Diagnosis, By Treatment, By End Users, By Region and COVID-19 Impact Analysis|
|Companies Covered:||Novartis AG , Abbvie, Inc, Bausch Health Companies Inc, Integra LifeSciences, Alcon, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Vertex Pharmaceuticals Incorporated, F. Hoffmann-La Roche Ltd, Fresnel Prism and Lens Co, Lancastle International Ltd, Good-Lite, RevitalVision, Vivid Vision, Inc|
|Pitfalls & Challenges:||COVID-19 Empact, Challenge, Future, Growth, & Analysis|
Get more details on this report -
The global rise in the incidence of ophthalmological illnesses such as refractive errors and cataracts is one reason driving the market. Additionally, favorable funding from the government for ophthalmic research is promoting market expansion in emerging nations like China, Mexico, and India. Also, the global amblyopia market is expanding as a result of rising consumer demand for affordable glasses and eye patches. In addition, modern amblyopia therapies have moved beyond patching for children and adults to assist patients of all ages in curing their conditions. Also, Customers are now encouraged to access amblyopia therapies anywhere in the world. Moreover, several significant market participants focused on releasing cutting-edge medical devices to cure amblyopia. The market for amblyopia treatments worldwide is anticipated to grow over the projected period.
The development of the amblyopia market is hampered by a lack of information regarding amblyopia treatments and a lack of stringent government regulation regarding innovative treatment techniques in emerging nations. Also, the expansion of the global amblyopia market over the forecast period may be hampered by a shortage of competent healthcare professionals who are unable to treat patients with the proper remedies. Moreover, global market expansion is constrained by a lack of technical innovation and a lack of resources.
- In 2022, the strabismus amblyopia segment is influencing the market with the largest market share over the forecast period.
On the basis of type, the global amblyopia market is into different segments such as strabismic amblyopia, refractive amblyopia, deprivation amblyopia, & others. Among these segments, the strabismus amblyopia segment dominates the largest market during the forecast period. because the number of people with strabismic amblyopia is increasing globally. The most frequent cause of amblyopia is strabismus.
Refractive amblyopia is the second-largest market share over the projected period, it is projected that an increase in the prevalence of refractive amblyopia would propel the sector. Anisotropic amblyopia affects 4.7% of children, according to the American Academy of Ophthalmology.
- In 2022, the visual acuity test segment is dominating the largest market growth during the forecast period.
Based on the diagnosis, the market for global amblyopia market is divided into several subsectors based including visual acuity tests and photo screening. The visual acuity tests segment held the highest market share during the forecast period. Before beginning therapy for amblyopia, it is a fundamental and essential test is performed. This area of the amblyopia market is expanding as a result of increased R&D efforts and ongoing Bruckner test advancements. Therefore, increasing demand for visual acuity tests for amblyopia has a favorable effect on market expansion.
- In 2022, the eye patch segment is leading the market with the largest market share during the forecast period.
On the basis of treatment, the global amblyopia market is segmented into segments such as glasses, eye patches, atropine drops, and surgery. Among these, the eye patch segment is dominating the highest market growth during the forecast period. This is due to wearing an eye patch that aids the weaker eye's vision and is a straightforward, affordable therapy for lazy eyes. Demand in this market is also being driven by the introduction of novel eye patches for the treatment of amblyopia. Video games are also becoming a cutting-edge therapeutic alternative.
- In 2022, the hospitals & pharmacies segment is dominating the largest market share over the forecast period.
Based on end users, the global amblyopia market is segmented into segments such as hospitals & pharmacies, and ophthalmic clinics. Among these, the hospitals & pharmacies are dominating the highest market growth during the forecast period owing to the treatment centers are easily accessible and a large portion of the business is also supported by end users' accessibility to hospitals and pharmacist's knowledge and expertise.
Regional Segment Analysis of the global amblyopia market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
Europe dominates the global amblyopia market with the largest market growth over the forecast period
Get more details on this report -
Europe dominated the amblyopia market and accounted for the highest revenue share due to there being modern medical facilities available, the government is supporting the expansion of the healthcare sector, The market is expanding in the area due to an increase in the number of amblyopia cases in Europe. Furthermore, the region's wealthy customers have a favorable impact on the market's expansion.
The North America amblyopia market is expected to grow at the fastest CAGR during the forecast period, owing to the medical sector's uses of cutting-edge technologies. Additionally, the simple accessibility of resources encourages the expansion of major firms and new entrants into the market in this region.
The report offers the appropriate analysis of the key organizations/companies involved within the global amblyopia market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Novartis AG
- Abbvie, Inc
- Bausch Health Companies Inc
- Integra LifeSciences
- Astellas Pharma Inc.
- Takeda Pharmaceutical Company Limited
- Vertex Pharmaceuticals Incorporated
- F. Hoffmann-La Roche Ltd
- Fresnel Prism and Lens Co
- Lancastle International Ltd
- Vivid Vision, Inc
Key Target Audience
- Market Players
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
- In March 2021, The Food and drug administration gave Novasight its approval to market Cure Sight as an amblyopia cure. While the user wears 3D glasses and views films, the technology educates the brain to utilize both eyes at once. The industry for amblyopia now has more room to flourish thanks to this approach.
- In October 2021, the global organization Orbis International, which mentors, educates, and motivates regional eye care specialists to prevent blindness in their communities, and HOYA Vision Care announced their alliance. This strategic alliance's primary goal is to close the global gap in vision care.
This study forecasts revenue at global, regional, and country levels from 2022 to 2032. Spherical Insights has segmented the Global Amblyopia Market based on the below-mentioned segments:
Global Amblyopia Market, By Type
- Strabismic Amblyopia
- Refractive Amblyopia
- Deprivation Amblyopia
Global Amblyopia Market, By Diagnosis
- Visual Acuity Test
- Photo Screening
Global Amblyopia Market, By Treatment
- Eye Patches
- Atropine Drops
Global Amblyopia Market, By End Users
- Hospitals & Pharmacies
- Ophthalmic Clinics
Amblyopia Market, By Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
Need help to buy this report?